Purchase in Installments of Compounded Drugs that do not have a Similar Commercial... Tender

Procurement Summary

Country : Brazil

Summary : Purchase in Installments of Compounded Drugs that do not have a Similar Commercial Presentation, in Dose and Concentration And/Or Pharmaceutical Form, and Items that Need Adaptation in a Pharmaceutical Form...

Deadline : 14 Jun 2023

Other Information

Notice Type : Tender

TOT Ref.No.: 83678215

Document Ref. No. : 48/2023

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Purpose: Electronic Auction - Acquisition in installments of compounded drugs that do not have a similar commercial presentation, in dose and concentration and/or pharmaceutical form, and items that need adaptation of pharmaceutical form for use in pediatrics/neonatology, and use via tube (AmiNOFILin 240mg amp and others), to assist patients hospitalized at the CHC/UFPR.

UASG Code: 155902

Edital from: 05/30/2023 from 8:00 am to 5:00 pm

Proposal Delivery: from 05/30/2023 at 08:00 AM

AMINOPHYLLINE, DOSAGE 24 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION

Quantity: 700

DYE, IT492584800e8c8d91eb93b064ebe674ebPO LUGOL FORTE, PHYSICAL APPEARANCE LIQUID, ADDITIONAL CHARACTERISTICS 5% SOLUTION

Amount : 28

BISMUTH SUBGALATE, PHYSICAL APPEARANCE WHITE TO YELLOW POWDER, ODORLESS, CHEMICAL FORMULA C7H5O6BI, MOLECULAR WEIGHT 394.09 G/MOL, PURE PURITY CONTENT MINIMUM ZA DE98%, ADDITIONAL FEATURE REAGENT USP, NUMBER492584800e8c8d91eb93b064ebe674ebCHEMICAL REFERENCE CAS 99-26-3

Quantity : 44

COLLODIUM ELASTIC, COMPOSITION: CAMPHOR 2%, CASTOR OIL 3% AND COLLODIUM QSP

Quantity : 16

CARNITINE, COMPOSITION L-ACETYLCARNITINE, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION, ADDITIONAL CHARACTERISTICS FORMULATION ESPECIALLY MANIPU492584800e8c8d91eb93b064ebe674ebLADA

Amount : 12

CHLORAL HYDRATE, CONCENTRATION 200 MG/ML, PHARMACEUTICAL FORM SYRUP, ADDITIONAL CHARACTERISTICS SPECIALLY MANIPULATED

Amount : 110

CHLORAL HYDRATE, CONCENTRATION 200 MG/ML, PHARMACEUTICAL FORM SYRUP, ADDITIONAL CHARACTERISTICS SPECIALLY MANIPULATED ADO

Quantity: 110

HYDRA492584800e8c8d91eb93b064ebe674ebCHLORAL TOUCH, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION, ADDITIONAL FEATURES SPECIALLY MANIPULATED

Quantity : 24

ACETIC ACID, CONCENTRATION* 2%, PHARMACEUTICAL FORM AQUEOUS SOLUTION

Quantity : 5

SORBITOL, PHYSICAL APPEARANCE SYRUPY LIQUID, LIQUID MPIDO, COLORLESS, CHEMICAL FORMULA C5492584800e8c8d91eb93b064ebe674ebH14O6 (1, 2, 3, 4, 5, 6-HExANEHExOL), MOLECULAR WEIGHT 182.17 G/MOL, PURITY CONTENT 70% CONTENT, REFERENCE NUMBER...

Documents

 Tender Notice